for the period from January 1 to December 31, 2022
|
|
Note |
2022 |
2021 |
|---|---|---|---|---|
Net profit/loss for the year |
|
(37,241) |
127,714 |
|
+ |
Amortization of intangible assets and depreciation of property, plant and equipment, right-of-use assets and depletion of biological assets |
227,589 |
164,269 |
|
+/– |
Change in the fair value of biological assets |
(17,009) |
(2,258) |
|
– |
Income from the release of investment grants |
|
(2,126) |
(1,944) |
+/– |
Change in non-current provisions |
|
(13,162) |
(4,908) |
–/+ |
Income / expenses from deferred taxes |
|
(5,579) |
6,838 |
+/– |
Change in current tax assets and liabilities |
|
(15,495) |
42,727 |
+/– |
Income from investments accounted for using the equity method |
|
1,062 |
4,431 |
–/+ |
Other non-cash income / expenses |
106,743 |
35,128 |
|
Gross cash flow |
|
244,783 |
371,999 |
|
|
|
|
|
|
+/– |
Change in inventories |
|
(295,952) |
(144,902) |
+/– |
Change in receivables |
|
10,581 |
(75,115) |
+/– |
Change in liabilities |
|
(2,657) |
242,049 |
Change in working capital |
|
(288,028) |
22,032 |
|
Cash flow from operating activities |
|
(43,246) |
394,030 |
|
|
|
|
|
|
– |
Acquisition of intangible assets, property, plant and equipment and biological assets (CAPEX) |
|
(698,894) |
(844,333) |
– |
Acquisition of financial assets and investments accounted for using the equity method |
|
(303) |
(7,328) |
+ |
Proceeds from the sale of intangible assets, property, plant and equipment and biological assets |
|
1,443 |
4,810 |
+ |
Proceeds from the sale/repayment of financial assets and the sale of investments accounted for using the equity method |
|
10,368 |
5,567 |
Cash flow from investing activities |
|
(687,387) |
(841,285) |
|
|
|
|
|
|
+ |
Capital injections to consolidated companies by non-controlling interests |
|
56,673 |
15,577 |
– |
Dividends paid (including hybrid coupon) |
(144,393) |
(28,925) |
|
+ |
Investment grants |
|
1,469 |
1,095 |
+ |
Increase in other financial liabilities |
258,907 |
626,384 |
|
– |
Repayment of bonds and private placements |
(72,000) |
(56,000) |
|
– |
Repayment of other financial liabilities |
(46,601) |
(87,584) |
|
Cash flow from financing activities |
|
54,056 |
470,548 |
|
|
|
|
|
|
Total change in liquid funds |
|
(676,576) |
23,293 |
|
|
|
|
|
|
Liquid funds at the beginning of the year |
|
1,113,279 |
1,069,998 |
|
Currency translation adjustment relating to liquid funds |
|
10,170 |
19,987 |
|
Liquid funds at the end of the year |
|
446,873 |
1,113,279 |
|
|
|
|
|
|
Additional information on payments in the cash flow from operating activities: |
|
|
|
|
Interest payments received |
|
10,756 |
3,963 |
|
Interest payments made |
|
74,631 |
34,315 |
|
Income taxes paid |
|
48,474 |
9,087 |
|
Distributions received from investments accounted for using the equity method |
|
840 |
890 |
|